Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Isotechnika Pharma Inc
IPHAF
Healthcare
Biotechnology
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IPHAF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
(2)
•••
labumba
X
View Profile
View Bullboard History
Post by
labumba
on Apr 01, 2010 3:32pm
Street perception.....
buy the stock now at 0.37 and make a decent profit shortly.....street perceives it is the best penny stock in town....they dont really care who Robert Foster is....they only care this drug wil be
...more
(0)
•••
antoninus
X
View Profile
View Bullboard History
Comment by
antoninus
on Apr 01, 2010 3:24pm
RE: RE: DANG! WON'T BE FOOLED AGAIN!
I'd rather have both. A wonderful drug and a management that understands perception. Maybe my point was lost on some eons ago, but running a publicly traded company requires a certain
...more
(0)
•••
Plato5
X
View Profile
View Bullboard History
Comment by
Plato5
on Apr 01, 2010 3:16pm
RE: DANG! WON'T BE FOOLED AGAIN!
Of course perceptions play a role - that's why the great Ponzi artists wear tailored three- piece suits. Many investors substitute perception for intelligence and research. But perception can be
...more
(48)
•••
ISAloser247
X
View Profile
View Bullboard History
Post by
ISAloser247
on Apr 01, 2010 2:40pm
DANG! WON'T BE FOOLED AGAIN!
.....doesn't seem like the $1 mark will be reached by Friday. Won't be really Good.Hope, everyone realizes that it is PERCEPTION! not Psychology. In particular, THE STREET'S
...more
(0)
•••
BornReady1970
X
View Profile
View Bullboard History
Comment by
BornReady1970
on Mar 31, 2010 10:18am
RE: RE: RE: Psychology
LOLI think anyone day trading can safely trade against my spin. I'm up the stocks down, I'm down the stocks up...
(2)
•••
labumba
X
View Profile
View Bullboard History
Comment by
labumba
on Mar 31, 2010 4:32am
RE: RE: Psychology
Waskerwisk, you got it right ! youre right about the market and the company.......Plato, you will make good money.....some patience will prevail..whats that guy born1970.....you need to give another
...more
(0)
•••
Plato5
X
View Profile
View Bullboard History
Comment by
Plato5
on Mar 31, 2010 2:50am
RE: RE: Psychology
Far more than two cents I'd say and far more than I expected. Your level and rational analysis speaks of much experience. Very much appreciated.
(0)
•••
WASKERWISK
X
View Profile
View Bullboard History
Comment by
WASKERWISK
on Mar 30, 2010 11:42pm
RE: Psychology
Well here are my two cents. There really isn’t that much uncertainty about the drug. It’s going to get approved. We’re going to make money. There isn’t even that much certainty about
...more
(0)
•••
Plato5
X
View Profile
View Bullboard History
Post by
Plato5
on Mar 30, 2010 10:04pm
Psychology
Would someone please offer some cogent analysis of today's trading. My guess is that the price remains depressed because as good as today's news is, we are still living in a sea of uncertainty
...more
(6)
•••
teevee
X
View Profile
View Bullboard History
Post by
teevee
on Mar 30, 2010 2:21pm
a good harbinger....
A good harbinger would be for the board to cancel the golden parachute(s).
(0)
•••
WASKERWISK
X
View Profile
View Bullboard History
Comment by
WASKERWISK
on Mar 30, 2010 2:12pm
RE: RE: isaloser
Huh? What on earth are you guys talking about? the article was fine, very good in fact and as somone has already pointed out gave what I thought was soem useful and better insight into what
...more
(0)
•••
professional11
X
View Profile
View Bullboard History
Post by
professional11
on Mar 30, 2010 1:47pm
LUX timeline very impressive
The LUX story is very impressive - Only 4 years and less than $100M to go from series A to FDA Approval For the short term investor – Voclosporine for UveitisMay 2006 $49M Series A (two
...more
(0)
•••
BornReady1970
X
View Profile
View Bullboard History
Comment by
BornReady1970
on Mar 30, 2010 1:42pm
RE: isaloser
I would agree that the article dampend what should have been a great day based on the FDA acceptance. Funny thing is, is he probably thought he was helping.
(0)
•••
antoninus
X
View Profile
View Bullboard History
Post by
antoninus
on Mar 30, 2010 12:40pm
isaloser
despite some here not liking what he has to say, he does raise a few decent points. the sweatshirt thing may seem trivial, but it matters. toally unprofessional. I noticed it too right away
...more
(0)
•••
macbethorfaust
X
View Profile
View Bullboard History
Post by
macbethorfaust
on Mar 30, 2010 12:07pm
nice
A good day. I would have thought we would settle in at a little over 40 cents though, but there you go.Remember that we are supposed to have anohter NDA, for Canada psoriasis, to go in within
...more
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income